The use of combination regenerative therapies for erectile dysfunction: rationale and current status
- 12 July 2021
- journal article
- research article
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 34 (8) , 735-738
Abstract
Erectile Dysfunction (ED) is defined as the inability to achieve and maintain an erection sufficient for sexual intercourse. Available treatments for ED provide only symptomatic relief, which is for the most part temporary. Regenerative therapies such as Low Intensity Shockwave, Platelet-Rich Plasma, and Stem Cell therapy can potentially provide a “cure” for ED by reversing the underlying pathology of ED rather than just treating the symptoms. Low Intensity Shockwave therapy is the most evidence based at this point and is thought to act by improving penile blood flow, repairing previous nerve damage, and activating stem cells. Stem Cell therapy takes advantage of the self-replicative potential of stem cells to create new corporal tissue, but also to recruit host cells and angiogenic factors to stimulate endogenous repair. Platelet-Rich Plasma therapy uses concentrated growth factors that already exist within the bloodstream to repair damaged nerves and increase penile blood flow. The use of combination restorative therapy may provide an additive or synergistic benefit greater than any one therapy alone because of its overlapping mechanisms of action on the penis but is a topic that remains to be studied.Keywords
This publication has 40 references indexed in Scilit:
- Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem CellsJournal of Osteopathic Medicine, 2016
- Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double‐blinded, placebo controlled studyInternational Journal of Urology, 2014
- Human Urine-Derived Stem Cells Alone or Genetically-Modified with FGF2 Improve Type 2 Diabetic Erectile Dysfunction in a Rat ModelPLOS ONE, 2014
- Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated GroupsArchives of Plastic Surgery, 2013
- Shockwave treatment of erectile dysfunctionTherapeutic Advances in Urology, 2013
- Low-Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor TherapyThe Journal of Sexual Medicine, 2012
- Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile DysfunctionEuropean Urology, 2010
- Stem and endothelial progenitor cells in erection biologyInternational Journal Of Impotence Research, 2008
- The additive erectile recovery effect of brain‐derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotenceBJU International, 2005
- The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injuryBJU International, 2004